• Leidenlaan 16, 6229 EZ Maastricht (NL)
  • +31 (0)43 32 85 191
  • Kerkplein 15 bus 3 3620 Lanaken (B)
  • +32 (0)89 84 54 52

NOVARTIS: STARTS TENDER OFFER FOR AVEXIS

17/04/2018

Swiss drugmaker Novartis said on Tuesday that it has begun a tender offer to acquire all of AveXis' common stock for 218 dollars a share in cash.

 

The tender offer will expire at midnight on 14 May, unless extended.

 

Last week Novartis said it would buy the Nasdaq-listed company in a deal worth 8.7 billion dollars, giving it the right to a gene therapy which could be used to fight spinal muscular atrophy.

 

Novartis also said this Tuesday that it would invest 100 million dollars to research and develop next-generation antimalarials as part of its commitment to eliminate malaria.

Copyright (c) 2018 CercleFinance.com. All rights reserved.
Wenst u graag vrijblijvend een afspraak? Laat het ons weten.